According to research reviewed by Gram, a 2026 rat study published in European Journal of Pharmacology found that butein, a natural plant compound, reduced kidney damage, lowered blood sugar, and cut inflammation in rats with diabetic kidney disease. These results come from animal experiments only, so benefits for people remain unproven.
Diabetes can slowly damage the kidneys, and current treatment options are limited. According to research reviewed by Gram, a new laboratory study tested butein, a natural compound found in some plants, in rats with diabetes-related kidney disease. The rats received butein for a period of time, and researchers compared the results to empagliflozin, a diabetes medicine already in use. Butein appeared to improve kidney function, reduce scarring and tissue damage, and lower blood sugar and fats in the blood. It also seemed to calm inflammation and reduce the number of kidney cells dying off. The researchers found that butein appears to work through several internal cell pathways that control stress, inflammation, and scarring. These findings are promising, but they come from animal experiments. Butein has not yet been tested in people, so its safety and benefits for humans remain unknown.
Key Statistics
A 2026 preclinical study published in the European Journal of Pharmacology found that butein reduced kidney damage and lowered blood sugar in rats with diabetes-related kidney disease, although the abstract did not specify the number of animals.
In the same 2026 rat study, butein treatment was reported to reduce inflammatory markers TNF-α and IL-1β and to lower the number of dying kidney cells, with empagliflozin used as the reference drug for comparison.
The Quick Take
- What they studied: Scientists wanted to know whether butein, a natural plant compound, could protect the kidneys from damage caused by diabetes and to understand how it might do so.
- Who participated: The study used laboratory rats that were fed a high-fat diet and given a drug called streptozotocin to create diabetes and kidney damage similar to diabetic kidney disease in people. The exact number of rats was not specified in the abstract.
- Key finding: Rats treated with butein showed less kidney damage, lower blood sugar, and lower levels of inflammation and cell death compared with untreated diabetic rats. The abstract does not report exact percentages or statistical measures, so the size of these effects is unclear.
- What it means for you: This is early laboratory research, not proof that butein helps people. It does not mean you should take butein supplements. If you have diabetes, keep following your doctor’s advice and ask them about kidney checkups.
The Research Details
The researchers combined two approaches. First, they used computer-based bioinformatics tools to predict which molecular pathways butein might affect in diabetic kidney disease. Then they tested those predictions in living rats. This lab work is called preclinical research, meaning it comes before studies in people.
To model the disease, the rats were fed a high-fat diet and given streptozotocin, a chemical that damages the cells in the pancreas that make insulin. Together, these steps produced diabetes and kidney damage that resemble what happens in people. The rats were then treated with butein, and some groups were treated with empagliflozin, a diabetes medicine used as a comparison.
The team measured kidney function, looked at kidney tissue under a microscope, and checked chemical markers in the blood and kidney tissue. These checks helped them see how butein affected stress, inflammation, scarring, and cell death.
Using animal models lets scientists control factors such as diet, timing, and dose, which is hard to do in people. Comparing butein to an approved drug gives a useful benchmark. Testing the same results in several ways, including tissue samples and blood tests, makes the findings more convincing. However, animal results often do not carry over to humans, so this step is best viewed as a first clue rather than a final answer.
The study combines several types of evidence, which is a strength. It also includes a reference drug for comparison. However, the abstract does not report the number of rats per group, exact statistical results, or how long the treatment lasted. Those details matter when judging how strong the findings are. The study was published in a peer-reviewed pharmacology journal, which means outside experts reviewed it before publication. Readers should still treat the results as preliminary until other labs repeat them and human studies are done.
What the Results Show
The main result was that butein appeared to protect the kidneys in diabetic rats. Treated rats showed improved kidney function and less damage to kidney tissue. Butein also reduced the buildup of extracellular matrix, which is the material that can harden and scar kidney tissue over time when it accumulates.
Butein also seemed to help with blood sugar and blood fats. Diabetes-related rises in blood sugar and fats decreased in the groups that received butein. Because diabetes drives much of the kidney damage, these effects on blood sugar may be part of how butein helps the kidneys.
The researchers also looked at how butein works inside cells. They reported that it appeared to strengthen the Nrf2/HO-1/GPX4 pathway, a system that helps cells defend against harmful oxidative stress. It also seemed to reduce a form of cell death called ferroptosis, and lowered a protein called ACSL4 that plays a role in this process.
Butein appeared to lower several inflammatory signals, including TNF-α, IL-1β, and COX2. These chemicals drive inflammation, which can worsen kidney injury. The study also reported fewer dying cells in kidney tissue, measured by caspase-3 and a test called TUNEL. Together, these results suggest that butein may reduce damage from multiple angles at once.
The researchers also reported that butein reduced activity in the PI3K/AKT/GSK3β pathway, a signaling network that controls cell growth, survival, and metabolism. Changes in this pathway are linked to kidney disease progression. The study suggests that butein may work partly by adjusting this pathway.
Diabetic kidney disease is a major complication of diabetes, and current treatments focus on controlling blood sugar and blood pressure and using medicines such as SGLT2 inhibitors like empagliflozin. Earlier research has shown that many natural plant compounds can reduce oxidative stress and inflammation in animal models, and butein belongs to this group. This study adds to that work by linking butein to several specific cell pathways involved in kidney scarring and cell death. Its results fit with the idea that targeting multiple pathways may be useful, but direct comparisons with other natural compounds in human studies are still needed.
The most important limitation is that this study was done in rats, not people. Results in animals do not always match results in humans, and doses that work in rats may not be safe or effective in people. The abstract also does not report the number of animals, the length of treatment, or exact statistical results, making it hard to judge the size or reliability of the effects. The study also relied on specific laboratory models, which may not capture all features of human diabetic kidney disease. Finally, butein’s long-term safety, how the body absorbs it, and proper doses are not yet known.
The Bottom Line
Confidence is low at this stage. The study provides a promising lead, but it does not show that butein is safe or effective for people with diabetic kidney disease. Based on this research alone, people should not start taking butein supplements. The most useful next step is human clinical trials, which have not yet been reported. Anyone with diabetes should continue evidence-based care, including blood sugar control, blood pressure management, and regular kidney tests, as recommended by their healthcare team.
Researchers studying kidney disease, diabetes, and natural compounds may find this work useful as a starting point. People living with diabetes or kidney disease may find it encouraging but should not change their treatment based on it. Anyone thinking about butein supplements should talk with a doctor or pharmacist first, especially if they take diabetes medicines, because interactions are possible. Healthy people without diabetes do not need to act on these findings.
Animal studies like this usually take several years to lead to human trials, and many compounds that look promising in animals never reach approval. If future human studies are successful, it could be a decade or more before any butein-based treatment becomes available. Anyone seeing this research in the news should expect a long road before it changes medical care.
Frequently Asked Questions
What is butein and can it help with diabetic kidney disease?
Butein is a natural plant compound. A 2026 rat study found it reduced kidney damage and inflammation in diabetic rats. It has not been tested in people, so its benefit for human diabetic kidney disease remains unproven.
Should I take butein supplements for diabetes or kidney health?
Current research does not support taking butein supplements. The evidence comes only from lab and animal studies. Talk with your doctor or pharmacist before taking any supplement, especially if you use diabetes medicines.
How did researchers test butein for kidney disease?
Researchers fed rats a high-fat diet and gave them streptozotocin to induce diabetes and kidney damage. They then treated the rats with butein and compared results to empagliflozin, an approved diabetes drug. The number of rats was not specified in the abstract.
What causes kidney damage in people with diabetes?
Long-term high blood sugar can injure the small blood vessels in the kidneys over time. Inflammation, oxidative stress, and tissue scarring can then reduce kidney function. Keeping blood sugar and blood pressure under control is a key way to slow this process.
Want to Apply This Research?
- Track fasting blood sugar and, if your doctor advises it, blood pressure in your app at the same time each day. Record your readings along with the date and any medicines you take. Also log your urine albumin or kidney function results from your lab visits, so you can see trends over time.
- Use the app to set a weekly reminder to review your blood sugar and blood pressure logs with your doctor. Add a daily habit such as drinking water, eating vegetables with each meal, and planning balanced meals with lower added sugar. Before adding any supplement, use the app to note the question and bring it to your next appointment.
- Review your logs monthly to spot patterns, such as how blood sugar changes with meals, exercise, or stress. Schedule kidney function tests with your healthcare provider at the frequency they recommend, and record each result in the app. Share summaries with your care team so decisions about treatment are based on accurate, complete information. Update your plan as new human research on butein or other compounds becomes available.
This article summarizes a laboratory study done in rats. Results in animals do not guarantee the same results in people, and butein has not been shown to be safe or effective for human diabetic kidney disease. Do not start, stop, or change any medicine or supplement based on this information. Talk with your doctor, kidney specialist, or pharmacist about your own treatment and health needs.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.